Aktie A2PRWA CAPSTONE HOLDING CORP.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Capstone Holding Corp.

Aktien

A2PRWA

US14068E2081

CAPS

Markt geschlossen - OTC Markets
Andere Börsenplätze
 17:28:02 10.05.2024 		% 5 Tage % 1. Jan.
4.625 USD -7.50% Intraday Chart für Capstone Holding Corp. 0.00% -11.06%
01.04. Capstone Holding Corp. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI
2023 Capstone Holding Corp. kündigt Wechsel im Vorstand an CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Capstone Holding Corp. Reports Earnings Results for the Full Year Ended December 31, 2023
Capstone Holding Corp. Announces Change in Board of Directors
Capstone Holding Corp. Announces CFO Change
Capstone Holding Corp. Reports Earnings Results for the Full Year Ended December 31, 2022
Capstone Therapeutics : Holding Corp. Announces Exercise Of Secured Debt And Interest Conversion Option By Majority Shareholder, BP Peptides, LLC
Capstone Therapeutics Corp. announced that it has received $1.498 million in funding
Capstone Therapeutics Corp. acquired an unknown stake Instone Co.
CAPSTONE THERAPEUTICS ANNOUNCES TRANSACTION WITH TOTALSTONE LLC
Capstone Therapeutics Corp. entered into an agreement to acquire an unknown stake in Instone Co.
Capstone Therapeutics Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2019
Capstone Therapeutics Corp. Reports Earnings Results for the First Quarter Ended March 31, 2019
Capstone Therapeutics Corp. Reports Earnings Results for the Full Year Ended December 31, 2018
Capstone Therapeutics Corp. Announces Executive Appointments
Capstone Therapeutics Corp. announced that it expects to receive $1.01 million in funding
Capstone Therapeutics Corp. Announces Resignation of Eric W. Fangmann from the Board of Directors and Audit Committee
Capstone Therapeutics Corp. announced that it has received $1 million in funding from BVF Partners LP
Capstone Therapeutics Corp. announced that it expects to receive $1 million in funding from BVF Partners LP
Capstone Therapeutics Corp. and LipimetiX Development, Inc. Announce Patent Application for Novel, More Potent Chimeric Apo E Mimetic Peptides
Capstone Therapeutics Qualifies Fangmann to Serve on the Company’s Board
Capstone Therapeutics Corp. Auditor Raises 'Going Concern' Doubt
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2PRWA Aktie
  4. Nachrichten Capstone Holding Corp.
  5. Andere Sprachen